Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status

  • 0Department of Functional Genomics, Medical University of Lodz, Zeligowskiego 7/9, 90-752, Lodz, Poland.

|

|

Summary

This summary is machine-generated.

This study identifies novel Wnt-associated gene panels for breast cancer (BC) diagnosis and prognosis. These biomarkers can help classify BC subtypes and improve patient outcomes.

Area Of Science

  • Oncology
  • Genomics
  • Bioinformatics

Background

  • Breast cancer (BC) is a leading cause of cancer death globally, necessitating improved diagnostic and prognostic tools.
  • The Wnt signaling pathway is implicated in BC progression, affecting cell cycle regulation and stem cell renewal.
  • Identifying novel biomarkers is crucial for early BC classification and enhanced patient outcomes.

Purpose Of The Study

  • To identify novel Wnt-associated biomarker panels for breast cancer (BC) patients.
  • To develop molecular signatures for BC subtype classification and survival prediction.
  • To leverage bioinformatic analyses for discovering diagnostic and prognostic markers.

Main Methods

  • Weighted gene co-expression network analysis (WGCNA)
  • Differential gene expression analysis
  • Kaplan-Meier survival analysis, logistic regression, and receiver operating characteristic (ROC) curve construction using The Cancer Genome Atlas (TCGA) data.

Main Results

  • Four distinct gene signatures were developed.
  • Two signatures differentiate ER+ from ER-BC: TTC8, SLC5A7, PLCH1 (overall survival - OS); ZNF695, SLC7A5, PLCH1 (disease-free survival - DFS).
  • Two signatures distinguish tumor from normal samples: SPC25, ANLN, KPNA2, SLC7A5 (OS); SPC25, KIF20A, SKA3, DTL, CDCA3, ANLN, TTK, RAD54L, MYBL2, ZNF695, SLC7A5 (DFS).

Conclusions

  • The identified gene signatures show potential as diagnostic and prognostic tools for breast cancer.
  • These Wnt-associated biomarkers could aid in classifying BC subtypes and predicting patient survival.
  • Comprehensive bioinformatic analysis of TCGA data provides a foundation for novel BC biomarker discovery.